Log in

Nutrien Stock Forecast, Price & News

+0.77 (+1.89 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $41.59
50-Day Range
MA: $37.40
52-Week Range
Now: $41.59
Volume2.55 million shs
Average Volume1.82 million shs
Market Capitalization$23.67 billion
P/E Ratio28.88
Dividend Yield4.41%
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Read More
Nutrien logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.12 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural chemicals



Sales & Book Value

Annual Sales$20.02 billion
Cash Flow$5.60 per share
Book Value$39.92 per share


Net Income$992 million


Market Cap$23.67 billion
Next Earnings Date11/2/2020 (Estimated)
+0.77 (+1.89 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Nutrien (NYSE:NTR) Frequently Asked Questions

How has Nutrien's stock been impacted by Coronavirus?

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR shares have increased by 30.0% and is now trading at $41.59.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Nutrien?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 7 hold ratings, 15 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien

When is Nutrien's next earnings date?

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Nutrien

How were Nutrien's earnings last quarter?

Nutrien Ltd (NYSE:NTR) posted its earnings results on Monday, August, 10th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.08. The company had revenue of $8.42 billion for the quarter, compared to analyst estimates of $8.32 billion. Nutrien had a return on equity of 4.26% and a net margin of 4.08%. The business's quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.58 earnings per share.
View Nutrien's earnings history

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien announced a quarterly dividend on Monday, August 10th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 annualized dividend and a yield of 4.33%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Nutrien's dividend history

What guidance has Nutrien issued on next quarter's earnings?

Nutrien issued an update on its FY20 earnings guidance on Monday, August, 10th. The company provided earnings per share (EPS) guidance of $1.50-1.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.62.

What price target have analysts set for NTR?

23 Wall Street analysts have issued 12 month price objectives for Nutrien's stock. Their forecasts range from $39.00 to $70.00. On average, they expect Nutrien's share price to reach $49.20 in the next year. This suggests a possible upside of 18.3% from the stock's current price.
View analysts' price targets for Nutrien

Are investors shorting Nutrien?

Nutrien saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 3,050,000 shares, an increase of 30.9% from the July 30th total of 2,330,000 shares. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is currently 1.9 days. Currently, 0.5% of the shares of the stock are short sold.
View Nutrien's Short Interest

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include Pfizer (PFE), AT&T (T), Intel (INTC), Johnson & Johnson (JNJ), Bank of America (BAC), General Electric (GE), AbbVie (ABBV), Micron Technology (MU), CVS Health (CVS) and JPMorgan Chase & Co. (JPM).

Who are Nutrien's key executives?

Nutrien's management team includes the following people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 49)
  • Mr. Frederick R. Thun, Sr. VP of Fin.
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 55)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 49)

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by many different institutional and retail investors. Top institutional shareholders include First Eagle Investment Management LLC (4.05%), Vanguard Group Inc. (3.05%), Jarislowsky Fraser Ltd (2.37%), TD Asset Management Inc. (1.83%), CIBC Asset Management Inc (1.49%) and Black Creek Investment Management Inc. (1.47%).

Which institutional investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, FMR LLC, Tocqueville Asset Management L.P., Hexavest Inc., Addenda Capital Inc., Cambiar Investors LLC, Vanguard Group Inc., and Bank of Nova Scotia.

Which institutional investors are buying Nutrien stock?

NTR stock was bought by a variety of institutional investors in the last quarter, including ARGA Investment Management LP, TD Asset Management Inc., QV Investors Inc., BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Toronto Dominion Bank, CIBC Asset Management Inc, First Eagle Investment Management LLC, and Jarislowsky Fraser Ltd.

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $41.59.

How big of a company is Nutrien?

Nutrien has a market capitalization of $23.67 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

What is Nutrien's official website?

The official website for Nutrien is www.nutrien.com.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.